Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
BIO-B
Bio-Rad Laboratories Inc
CAPPED RATING
Bio-Rad Laboratories Inc (BIO-B) is rated C (2.2/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (C+); its weakest is Growth (D).
Quantitative Factor Evaluation • Updated
Overall Rating
2.2
/ 5.0
C
Value
C
Factor Score
2.4
/ 5.0
Growth
D
Factor Score
1.3
/ 5.0
Profitability
C+
Factor Score
2.8
/ 5.0
Momentum
C
Factor Score
2.4
/ 5.0
Revisions
C-
Factor Score
1.9
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
56.2
EV / EBITDA
19.2
Rev Growth YoY
1.1%
Gross Margin
52.0%
Price Return 3M
8.5%
Price Return 12M
N/A
Catalyst Signal
0.00
Market Cap
N/A
TTM Revenue
N/A
Price / Sales
3.5
ROE
2.5%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-08-05 | C (2.4) | D (1.3) | C+ (2.8) | C (2.4) | C- (1.9) | C (2.2) |
| 2026-08-04 | C (2.4) | D (1.3) | C+ (2.8) | C (2.4) | C- (1.9) | C (2.2) |
| 2026-08-03 | C (2.4) | C- (2.0) | B- (3.0) | C (2.4) | C- (2.0) | C (2.4) |
| 2026-08-02 | C (2.4) | C- (2.0) | B- (2.9) | C (2.4) | C- (1.9) | C (2.3) |